Drug news
FDA approves Juvderm Voluma XC (Allergan) facial filler
Allergan, has announced that the company has received approval from the FDA to market JUV�DERM VOLUMA XC, the first and only filler approved to temporarily correct age-related volume loss in the cheek area in adults over the age of 21. Juvederm Voluma XC helps create a more youthful appearance to the face and provides natural-looking and long-lasting results up to two years with optimal treatment.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins